Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
Patent No. EP2215124 (titled "Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)") was filed by Amgen on Aug 22, 2008. The application was issued on Dec 27, 2023.
Patent Summary
Patent Family
Patent Oppositions (5)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents
EP2215124
- Filing Date
- Aug 22, 2008
- Status
- Granted
- Publication Date
- Dec 27, 2023
- External Links
- Slate, Register , Google Patents